About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker SPRB

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Aug 14, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
AWM Investment Company, Inc.146,9885.1%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Daniel Schneeberger67,7172.5%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
ADAR1 Capital Management, LLC67,7172.5%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Kenneth Griffin51,9191.9%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities GP LLC4,9590.2%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities Group LP4,9590.2%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities LLC1,6840.1%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel GP LLC46,9601.7%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Advisors Holdings LP46,9601.7%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Advisors LLC46,9601.7%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
OrbiMed Capital LLC67,8002.5%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
OrbiMed Advisors LLC132,2004.8%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Israel A. Englander160,9815.8%SCHEDULE 13G/A ↗
Aug 4, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Millennium Group Management LLC160,9815.8%SCHEDULE 13G/A ↗
Aug 4, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Millennium Management LLC160,9815.8%SCHEDULE 13G/A ↗
Aug 4, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Integrated Core Strategies (US) LLC160,9815.8%SCHEDULE 13G/A ↗
Jul 30, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
BlackRock, Inc.187,8366.8%SCHEDULE 13G ↗
Jul 27, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
AIGH Capital Management LLC250,0009.1%SCHEDULE 13G ↗
Jul 27, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Orin Hirschman250,0009.1%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
William Blank12,2000.9%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Matthew Sesterhenn12,2000.9%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Squadron Capital Management LLC12,2000.9%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Squadron Master Fund LP12,2000.9%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Anand Parekh61,6704.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Alyeska Fund GP, LLC61,6704.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Alyeska Investment Group, L.P.61,6704.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Kenneth Griffin70,0655.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities GP LLC660.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities Group LP660.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Securities LLC660.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel GP LLC69,9995.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Advisors Holdings LP69,9995.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Citadel Advisors LLC69,9995.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Wellington Investment Advisors Holdings LLP48,7963.6%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Wellington Group Holdings LLP48,7963.6%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Wellington Management Group LLP48,7963.6%SCHEDULE 13G/A ↗
May 7, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Neil Shahrestani121,3564.8%SCHEDULE 13G/A ↗
May 7, 2026SCHEDULE 13G/A (amended)SPRB
Spruce Biosciences, Inc.
Ikarian Capital, LLC121,3564.8%SCHEDULE 13G/A ↗
Apr 28, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Michael Gelband22,0000.8%SCHEDULE 13G ↗
Apr 28, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
ExodusPoint Capital Partners GP, LLC22,0000.8%SCHEDULE 13G ↗
Apr 28, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
ExodusPoint Capital Management, LP22,0000.8%SCHEDULE 13G ↗
Feb 24, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Israel A. Englander103,0269.6%SCHEDULE 13G ↗
Feb 24, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Millennium Group Management LLC103,0269.6%SCHEDULE 13G ↗
Feb 24, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Millennium Management LLC103,0269.6%SCHEDULE 13G ↗
Feb 24, 2026SCHEDULE 13GSPRB
Spruce Biosciences, Inc.
Integrated Core Strategies (US) LLC102,9719.6%SCHEDULE 13G ↗
Feb 18, 2026SCHEDULE 13D/A (amended)SPRB
Spruce Biosciences, Inc.
Abingworth Bioventures VII LP50,8934.7%SCHEDULE 13D/A ↗
Feb 18, 2026SCHEDULE 13D/A (amended)SPRB
Spruce Biosciences, Inc.
Abingworth LLP50,8934.7%SCHEDULE 13D/A ↗
Feb 18, 2026SCHEDULE 13D/A (amended)SPRB
Spruce Biosciences, Inc.
Carlyle Genesis UK LLC50,8934.7%SCHEDULE 13D/A ↗
Feb 18, 2026SCHEDULE 13D/A (amended)SPRB
Spruce Biosciences, Inc.
Carlyle Investment Management L.L.C.50,8934.7%SCHEDULE 13D/A ↗
Feb 18, 2026SCHEDULE 13D/A (amended)SPRB
Spruce Biosciences, Inc.
TC Group, L.L.C.50,8934.7%SCHEDULE 13D/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 10:00 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances